Concepedia

Matthew Crowe

MC

Statistics

Publications

2

Citations

32

H-Index

2

Active since

2012

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Matthew Crowe is an author at GlaxoSmithKline (United Kingdom) specializing in signal transduction, immunology, and obesity metabolism.

ORCID

Publications per year

2012–2018

2

Publications

2

A novel series of benzimidazole NR2B-selective NMDA receptor antagonists

D.J.G. Davies, Matthew Crowe, Nolwenn Lucas et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 17 citations · Full text

, , +10

Deletion of the Duffy antigen receptor for chemokines (DARC) promotes insulin resistance and adipose tissue inflammation during high fat feeding

Tyler W. Benson, Daniel S. Weintraub, Matthew Crowe et al. · Molecular and Cellular Endocrinology · 2018 · 15 citations · Full text

, , +17

1–2 of 2